Brain Tumor Diagnosis And Therapeutics Market Size, Share & Trends Analysis Report By Type, By Product (Stains & Varnishes, Shellacs), By Diagnosis, By Therapeutics, By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Bowel Management Systems Market Growth & Trends
The global bowel management systems market is expected to reach USD 2.19 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.4% from 2024 to 2030. Rising incidence of fecal incontinence coupled with growing government initiatives to raise awareness about bowel management is likely to drive the market. Furthermore, a favorable reimbursement scenario has also been favoring the growth of the market.
Bowel management systems are an important tool to manage fecal incontinence. According to the International Foundation for Gastrointestinal Disorders, fecal incontinence affects 6.9% of adult females and 7.4% of adult males. It has also been estimated that around 20.0% of people with irritable bowel syndrome have bowel incontinence.
In addition, different organizations such as United Ostomy Associations of America, Inc., and Colostomy U.K. are working towards raising awareness about ostomy. They are focused on empowering and supporting people who have had an ostomy. Also, government bodies globally are introducing programs to provide support to individuals with a stoma by improving access to clinically appropriate and most suitable stoma-related products. These are some of the factors that are promoting the growth of the market.
Bowel Management Systems Market Report Highlights
Bowel Management Systems Market Growth & Trends
The global bowel management systems market is expected to reach USD 2.19 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.4% from 2024 to 2030. Rising incidence of fecal incontinence coupled with growing government initiatives to raise awareness about bowel management is likely to drive the market. Furthermore, a favorable reimbursement scenario has also been favoring the growth of the market.
Bowel management systems are an important tool to manage fecal incontinence. According to the International Foundation for Gastrointestinal Disorders, fecal incontinence affects 6.9% of adult females and 7.4% of adult males. It has also been estimated that around 20.0% of people with irritable bowel syndrome have bowel incontinence.
In addition, different organizations such as United Ostomy Associations of America, Inc., and Colostomy U.K. are working towards raising awareness about ostomy. They are focused on empowering and supporting people who have had an ostomy. Also, government bodies globally are introducing programs to provide support to individuals with a stoma by improving access to clinically appropriate and most suitable stoma-related products. These are some of the factors that are promoting the growth of the market.
Bowel Management Systems Market Report Highlights
- The colostomy bags dominated the market and accounted for the largest revenue share of 45.2% in 2023.
- Adult patients led the market and accounted for the largest revenue share of 67.9% in 2023. This growth is attributed to the rising prevalence of colorectal cancer; individuals with symptoms of inability to control bowel movements, inadequate emptying, or chronic constipation benefit from bowel management systems.
- The home care segment held the largest revenue share, 58.4%, in 2023, owing to the significant usage and rising adoption of bowel management systems in home care settings.
- North America bowel management systems market dominated the global market and accounted for the largest revenue share of 36.1% in 2023.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Brain Tumor Diagnosis And Therapeutics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Brain Tumor Diagnosis And Therapeutics Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Primary
4.3.1. Primary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Meningioma
4.3.2.1. Meningioma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Gliomas
4.3.3.1. Gliomas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Astrocytomas
4.3.4.1. Astrocytomas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Pituitary Tumors
4.3.5.1. Pituitary Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.7. Secondary
4.3.8. Secondary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Brain Tumor Diagnosis And Therapeutics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
5.3. Stains & Varnishes
5.3.1. Stains & Varnishes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Shellacs
5.4.1. Shellacs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Lacquers
5.5.1. Lacquers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: DIAGNOSIS ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Brain Tumor Diagnosis and Therapeutics Market: Diagnosis Movement Analysis, 2023 & 2030 (USD Million)
6.3. MRI
6.3.1. MRI Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. CT scan
6.4.1. CT scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Tissue Sampling
6.5.1. Tissue Sampling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. PET-CT scan
6.6.1. PET-CT scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Cerebral Arteriogram
6.7.1. Cerebral Arteriogram Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Lumbar Puncture
6.8.1. Lumbar Puncture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Molecular Testing
6.9.1. Molecular Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. EEG
6.10.1. EEG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: THERAPEUTICS ESTIMATES & TREND ANALYSIS
7.1. Brain Tumor Diagnosis and Therapeutics Market Share, By Therapeutics, 2023 & 2030, USD Million
7.2. Surgery
7.2.1. Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Radiation Therapy
7.3.1. Radiation Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Chemotherapy
7.4.1. Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Immunotherapy
7.5.1. Immunotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Targeted Therapy
7.6.1. Targeted Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Brain Tumor Diagnosis and Therapeutics Market Share, By End Use, 2023 & 2030, USD Million
8.2. Hospitals
8.2.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Oncology Treatment Centers
8.3.1. Oncology Treatment Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Others
8.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Brain Tumor Diagnosis and Therapeutics Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Mexico Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. UK
9.3.2.1. UK Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. France Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Italy Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Spain Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Denmark Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Sweden Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Norway Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. China
9.4.2.1. China Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. Japan
9.4.3.1. Japan Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. India Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. South Korea
9.4.5.1. South Korea Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. Australia
9.4.6.1. Australia Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Thailand Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Argentina Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. UAE
9.6.3.1. UAE Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. South Africa
9.6.4.1. South Africa Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Kuwait Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.4.1. Amgen Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Recent Developments/ Strategic Initiatives
10.4.2. AstraZeneca
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Recent Developments/ Strategic Initiatives
10.4.3. Bayer AG
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Recent Developments/ Strategic Initiatives
10.4.4. GE HealthCare
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Recent Developments/ Strategic Initiatives
10.4.5. F. Hoffmann-La Roche Ltd
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Recent Developments/ Strategic Initiatives
10.4.6. Eisai Co., Ltd.
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Recent Developments/ Strategic Initiatives
10.4.7. Bristol-Myers Squibb Company
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Recent Developments/ Strategic Initiatives
10.4.8. Pfizer Inc.
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Recent Developments/ Strategic Initiatives
10.4.9. Shimadzu Corporation
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Recent Developments/ Strategic Initiatives
10.4.10. Siemens Healthineers AG
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Brain Tumor Diagnosis And Therapeutics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Brain Tumor Diagnosis And Therapeutics Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Primary
4.3.1. Primary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Meningioma
4.3.2.1. Meningioma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Gliomas
4.3.3.1. Gliomas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Astrocytomas
4.3.4.1. Astrocytomas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Pituitary Tumors
4.3.5.1. Pituitary Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.7. Secondary
4.3.8. Secondary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Brain Tumor Diagnosis And Therapeutics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
5.3. Stains & Varnishes
5.3.1. Stains & Varnishes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Shellacs
5.4.1. Shellacs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Lacquers
5.5.1. Lacquers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: DIAGNOSIS ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Brain Tumor Diagnosis and Therapeutics Market: Diagnosis Movement Analysis, 2023 & 2030 (USD Million)
6.3. MRI
6.3.1. MRI Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. CT scan
6.4.1. CT scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Tissue Sampling
6.5.1. Tissue Sampling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. PET-CT scan
6.6.1. PET-CT scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Cerebral Arteriogram
6.7.1. Cerebral Arteriogram Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Lumbar Puncture
6.8.1. Lumbar Puncture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Molecular Testing
6.9.1. Molecular Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. EEG
6.10.1. EEG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: THERAPEUTICS ESTIMATES & TREND ANALYSIS
7.1. Brain Tumor Diagnosis and Therapeutics Market Share, By Therapeutics, 2023 & 2030, USD Million
7.2. Surgery
7.2.1. Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Radiation Therapy
7.3.1. Radiation Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Chemotherapy
7.4.1. Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Immunotherapy
7.5.1. Immunotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Targeted Therapy
7.6.1. Targeted Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Brain Tumor Diagnosis and Therapeutics Market Share, By End Use, 2023 & 2030, USD Million
8.2. Hospitals
8.2.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Oncology Treatment Centers
8.3.1. Oncology Treatment Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Others
8.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Brain Tumor Diagnosis and Therapeutics Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Mexico Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. UK
9.3.2.1. UK Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. France Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Italy Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Spain Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Denmark Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Sweden Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Norway Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. China
9.4.2.1. China Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. Japan
9.4.3.1. Japan Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. India Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. South Korea
9.4.5.1. South Korea Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. Australia
9.4.6.1. Australia Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Thailand Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Argentina Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. UAE
9.6.3.1. UAE Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. South Africa
9.6.4.1. South Africa Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Kuwait Brain Tumor Diagnosis and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.4.1. Amgen Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Recent Developments/ Strategic Initiatives
10.4.2. AstraZeneca
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Recent Developments/ Strategic Initiatives
10.4.3. Bayer AG
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Recent Developments/ Strategic Initiatives
10.4.4. GE HealthCare
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Recent Developments/ Strategic Initiatives
10.4.5. F. Hoffmann-La Roche Ltd
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Recent Developments/ Strategic Initiatives
10.4.6. Eisai Co., Ltd.
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Recent Developments/ Strategic Initiatives
10.4.7. Bristol-Myers Squibb Company
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Recent Developments/ Strategic Initiatives
10.4.8. Pfizer Inc.
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Recent Developments/ Strategic Initiatives
10.4.9. Shimadzu Corporation
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Recent Developments/ Strategic Initiatives
10.4.10. Siemens Healthineers AG
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Recent Developments/ Strategic Initiatives
